ZERO WINTERDEAL 2025: Bis zu 300 € Prämie + Gratis-Aktie + finanzen.net MSCI World-ETF -
Jetzt informieren!
NASDAQ 100
25.229,13
PKT
+131,71
PKT
+0,52
%
Indikation, realtime*
25.097,42
PKT
+218,41
PKT
+0,88
%
Offiziell
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.12 | QUALCOMM overweight | Barclays Capital | |
| 03.02.12 | Amazon neutral | Credit Suisse Group | |
| 03.02.12 | QUALCOMM buy | D.A. Davidson & Co. | |
| 03.02.12 | QUALCOMM outperform | Pacific Crest Securities Inc. | |
| 03.02.12 | Linde outperform | Credit Suisse Group | |
| 03.02.12 | QUALCOMM outperform | RBC Capital Markets | |
| 03.02.12 | Electronic Arts sell | Deutsche Bank Securities | |
| 03.02.12 | QUALCOMM buy | Deutsche Bank Securities | |
| 02.02.12 | QUALCOMM outperform | Oppenheimer & Co. Inc. | |
| 02.02.12 | QUALCOMM buy | UBS AG | |
| 02.02.12 | Apple overweight | Piper Jaffray & Co. | |
| 02.02.12 | Amazon buy | Citigroup Corp. | |
| 02.02.12 | Tesla buy | Jefferies & Company Inc. | |
| 02.02.12 | Amazon buy | Deutsche Bank Securities | |
| 02.02.12 | Amazon neutral | Nomura | |
| 02.02.12 | Apple overweight | Barclays Capital | |
| 02.02.12 | Amazon outperform | RBC Capital Markets | |
| 02.02.12 | Amazon outperform | Macquarie Research | |
| 02.02.12 | Biogen overweight | Barclays Capital | |
| 02.02.12 | Vertex Pharmaceuticals overweight | Barclays Capital | |
| 02.02.12 | Biogen outperform | RBC Capital Markets | |
| 02.02.12 | Align Technology outperform | Barrington Research | |
| 02.02.12 | Amazon neutral | Goldman Sachs Group Inc. | |
| 02.02.12 | Amazon outperform | RBC Capital Markets | |
| 02.02.12 | Microsoft buy | Sarasin Research | |
| 02.02.12 | Amazon buy | Jefferies & Company Inc. | |
| 02.02.12 | Amazon buy | Stifel, Nicolaus & Co., Inc. | |
| 01.02.12 | Amazon outperform | Oppenheimer & Co. Inc. | |
| 01.02.12 | Charter A sector outperform | Scotia Capital Markets | |
| 01.02.12 | Amgen verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 31.01.12 | Apple halten | Independent Research GmbH | |
| 31.01.12 | Strategy (ex MicroStrategy) neutral | UBS AG | |
| 31.01.12 | Starbucks sector perform | RBC Capital Markets | |
| 31.01.12 | Cisco sector perform | RBC Capital Markets | |
| 31.01.12 | Honeywell buy | Nomura | |
| 31.01.12 | Starbucks outperform | Williams Capital | |
| 30.01.12 | Linde outperform | Macquarie Research | |
| 30.01.12 | Honeywell outperform | Oppenheimer & Co. Inc. | |
| 30.01.12 | Starbucks equal-weight | Barclays Capital | |
| 30.01.12 | Ross Stores buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.